129 related articles for article (PubMed ID: 11602377)
1. The mechanisms of neoplastic transformation.
Luzzatto L
Eur J Cancer; 2001 Oct; 37 Suppl 8():S114-7. PubMed ID: 11602377
[No Abstract] [Full Text] [Related]
2. Fgf-3, an oncogene in murine breast cancer.
Dickson C; Fantl V
Cancer Treat Res; 1994; 71():331-43. PubMed ID: 7946957
[No Abstract] [Full Text] [Related]
3. Immortalization and malignant transformation of differentiated cells by oncogenes in vitro and in transgenic mice.
Paul D; Schmidt GH
Crit Rev Oncog; 1989; 1(3):307-21. PubMed ID: 2488135
[No Abstract] [Full Text] [Related]
4. Some characteristics of neoplastic cell transformation in transgenic mice.
Shvemberger IN; Ermilov AN
Int Rev Cytol; 1996; 164():37-90. PubMed ID: 8575893
[TBL] [Abstract][Full Text] [Related]
5. The role of bcl-2 in lymphoid differentiation and neoplastic transformation.
Strasser A; Harris AW; Cory S
Curr Top Microbiol Immunol; 1992; 182():299-302. PubMed ID: 1490367
[No Abstract] [Full Text] [Related]
6. Snapshot: genetic mouse models of cancer.
Zender L; Zuber J; Lowe SW
Cell; 2007 May; 129(4):838. PubMed ID: 17512415
[No Abstract] [Full Text] [Related]
7. [Transgenic mice as models for human diseases].
Babinet C
Rev Prat; 1990 Sep; 40(20):1859-62. PubMed ID: 2218352
[No Abstract] [Full Text] [Related]
8. Defining the mechanisms of transformation through analysis of revertant cells.
Bassin RH; Benade LE
Immunol Ser; 1990; 51():15-47. PubMed ID: 2095917
[No Abstract] [Full Text] [Related]
9. Insulin-like growth factors: the unrecognised oncogenes.
Westley BR; May FE
Br J Cancer; 1995 Nov; 72(5):1065-6. PubMed ID: 7577447
[No Abstract] [Full Text] [Related]
10. [Transgenic mice for analysis of neoplasm transformation processes of T and B lymphocytes].
Kobzdej M; Strzadała L
Postepy Hig Med Dosw; 1996; 50(2):113-29. PubMed ID: 8848421
[TBL] [Abstract][Full Text] [Related]
11. Immortalization of neuroendocrine cells by targeted oncogenesis.
Mellon PL; Windle JJ; Weiner RI
Recent Prog Horm Res; 1991; 47():69-93; discussion 93-6. PubMed ID: 1745826
[No Abstract] [Full Text] [Related]
12. Transgenic mouse models of mammary tumorigenesis.
Cardiff RD; Muller WJ
Cancer Surv; 1993; 16():97-113. PubMed ID: 8394206
[No Abstract] [Full Text] [Related]
13. Animal models and the molecular pathology of cancer.
Lovejoy EA; Clarke AR; Harrison DJ
J Pathol; 1997 Feb; 181(2):130-5. PubMed ID: 9120714
[No Abstract] [Full Text] [Related]
14. Oncogenes and their mechanisms of action.
Găldean D
Roum Arch Microbiol Immunol; 1992; 51(1-2):75-99. PubMed ID: 1457825
[No Abstract] [Full Text] [Related]
15. Insights into cancer from transgenic mouse models.
Macleod KF; Jacks T
J Pathol; 1999 Jan; 187(1):43-60. PubMed ID: 10341706
[TBL] [Abstract][Full Text] [Related]
16. Oncogenes and cancer.
Duesberg PH
Science; 1995 Mar; 267(5203):1407-8. PubMed ID: 7794335
[No Abstract] [Full Text] [Related]
17. [Malignant cell transformation and oncogenes].
Kiselev FL
Genetika; 1985 Jun; 21(6):885-95. PubMed ID: 3928437
[TBL] [Abstract][Full Text] [Related]
18. Retroviral oncogenes: interrelationships between neoplastic transformation and cell differentiation.
Auersperg N; Roskelley C
Crit Rev Oncog; 1991; 2(2):125-60. PubMed ID: 1854833
[No Abstract] [Full Text] [Related]
19. Transgenic mouse with human mutant p53 expression in the prostate epithelium.
Elgavish A; Wood PA; Pinkert CA; Eltoum IE; Cartee T; Wilbanks J; Mentor-Marcel R; Tian L; Scroggins SE
Prostate; 2004 Sep; 61(1):26-34. PubMed ID: 15287091
[TBL] [Abstract][Full Text] [Related]
20. A novel stimulus, oncogene, induces expression of CD80 (B7-1) gene.
Zhang H; Haasch D; Patterson B; Dickinson B; Kifle L; Fry DG; Okasinski GF
Tumour Biol; 1999; 20(4):193-201. PubMed ID: 10393529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
